Skip to content

EverBridge Group Seals Pioneering Agreement with Cosmotec

Expanded skincare distribution opportunities and shared public relations assets for beauty marketers are now available thanks to the launch of 2,000 doors and T Mall's flagship store within a ninety-day period in the APAC region.

EverBridge Group Enters into Groundbreaking Collaboration with Cosmotec
EverBridge Group Enters into Groundbreaking Collaboration with Cosmotec

EverBridge Group Seals Pioneering Agreement with Cosmotec

In a significant move towards global expansion, EverBridge Group has entered into an exclusive commercialization partnership with Cosmotec Inc., a Wholly Owned Subsidiary of M3, Inc. This partnership, announced on September 15, 2025, marks a milestone in EverBridge Group's global entry strategy.

The partnership is focused on the Japanese market and aims to accelerate the adoption of EverBridge Group's devices in the region. This will be achieved through the integration of M3's academic platforms with Cosmotec's localized commercialization expertise.

Cosmotec's digital commercialization model, recognised as best-in-class, delivers both efficiency and accessibility. EverBridge Group's CEO, Jay Wang, has mentioned that this model aligns with EverBridge Group's vision for equitable healthcare innovation.

Suguru Ominato, CEO of Cosmotec, praised EverBridge Group's portfolio, stating that it showcases exceptional clinical efficiency and user-friendly design. This partnership is expected to deliver transformative solutions to patients in Japan while enhancing the global R&D synergy between EverBridge Group and Cosmotec.

EverBridge Group's involvement in this partnership also highlights its commitment to stringent regulatory compliance and proprietary R&D leadership. The platform, which enables targeted engagement with clinical end-users, will accelerate market access for international medical devices.

The partnership amplifies EverBridge Group's international influence and underscores its commitment to delivering transformative solutions to patients and enhancing global R&D synergy. EverBridge Group's vision for globalization includes lowering barriers to advanced care through innovation and ecosystem collaboration.

Read also:

Latest